1. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014. Available from: http://seer.cancer.gov/csr/1975_2011.
2. Advanced pancreatic carcinoma: current treatment and future challenges;A Stathis;Nat Rev Clin Oncol,2010
3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;HA Burris 3rd;J Clin Oncol,1997
4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;V Vaccaro;N Engl J Med
5. Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition;MD Bacolod;Ann Surg Oncol